The Zhitong Finance App learned that Health 160 (02656) fluctuated and declined today. The intraday low was HK$6.99, a new low since listing. The stock price has retreated by more than 95% from the highest point in March this year. As of press release, it decreased by 7.28% to HK$7, with a turnover of HK$389.08 million.
According to the news, Health 160 was listed on September 17, 2025, and has now expired for one year. The sales ban promises of its controlling shareholder and pre-initial public offering investors expired on September 16. According to data, a total of 28 shareholders have lifted the ban this time, with a total of about 164 million shares unbanned. Furthermore, March of this year was supposed to be the first batch of days the company lifted the ban, but on March 13, the company announced that it would voluntarily extend the initial sales ban promise for six months until September 16, 2026.
The company recently disclosed that its indirect wholly-owned subsidiary Shenzhen 160 Network Technology Co., Ltd. signed a strategic cooperation framework agreement with a limited liability company registered in Shenzhen, China. The partners initially agreed to purchase enterprise-grade AI computing power infrastructure of a certain scale. The estimated total cooperation amount is about RMB 650 million. The agreement is valid for one year. According to the announcement, the partner focuses on the field of enterprise-level computing power infrastructure, provides services such as equipment leasing and AI cloud computing power, and is a national high-tech enterprise established for more than 10 years.